Return to Listing

2 result(s) for Paraplatin

PI Name Protocol # Title
Kathleen Kemmer IRB00011351 A Phase 3 Randomized, Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the PARP Inhibitor Veliparib (ABT-888) in HER2-Negative Metastatic or Locally Advanced Unresectable BRCA-Associated Breast Cancer
Jeremy Cetnar IRB00011845 A phase III, open label, randomized study of MPDL3280A (anti-pdl1 antibody) compared with cisplatin or carboplatin + pemetrexed for PDL1- selected chemotherapy naive patients with stage IV non -squamous non small cell lung cancer
 

You may also qualify for Phase 1 Program trials.

 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080